Human papillomavirus infection during pregnancy and childhood: a comprehensive review

A Ardekani, E Taherifard, A Mollalo, E Hemadi… - Microorganisms, 2022 - mdpi.com
Human papillomavirus (HPV), the most prevalent sexually transmitted disease worldwide, is
the causative agent for several genital and oropharyngeal cancers and a suspected agent …

Review of the evidence of the effects of human papillomavirus infection and Gardnerella vaginalis, and their co-infection on infertility

O Gholizadeh, Z Yekanipour, S Kivi, F Farahbod… - Microbial …, 2023 - Elsevier
A prevalent sexually transmitted infection, the human papillomavirus (HPV) is typically
obtained just after the first sexual activity. The majority of HPV infections are asymptomatic …

Inequities in screening and HPV vaccination programs and their impact on cervical cancer statistics in Romania

L Simion, V Rotaru, C Cirimbei, L Gales, DC Stefan… - Diagnostics, 2023 - mdpi.com
(1) Introduction: A Romanian woman is diagnosed with cervical cancer every two hours; the
country ranks second in Europe in terms of the mortality and incidence rate of this disease …

Maternal HPV infection and the estimated risks for adverse pregnancy outcomes—a systematic review

SD Popescu, AG Boiangiu, RM Sima, L Bilteanu… - Diagnostics, 2022 - mdpi.com
Background: Human Papilloma Virus (HPV) represents the most prevalent genital infection
in young women of reproductive age. Objective: This systematic review aims to estimate the …

Unraveling Immunological Dynamics: HPV Infection in Women—Insights from Pregnancy

CE Condrat, D Cretoiu, VE Radoi, DM Mihele… - Viruses, 2023 - mdpi.com
During pregnancy, hormonal and immune adaptations are vital for supporting the genetically
distinct fetus during elevated infection risks. The global prevalence of HPV necessitates its …

[HTML][HTML] Empowering women's Health: insights Into HPV vaccination and the prevention of invasive cervical cancer

S Rathod, J Potdar, A Gupta, N Sethi, A Dande - Cureus, 2023 - ncbi.nlm.nih.gov
This review article provides a comprehensive analysis of the role of human papillomavirus
(HPV) vaccination in empowering women's health by preventing invasive cervical cancer …

In-silico molecular modeling studies to identify novel potential inhibitors of HPV E6 protein

M Soumia, H Hajji, M El Mzibri, FZ Younes… - Vaccines, 2022 - mdpi.com
The etiological agent of some anogenital tract cancers is infection with the high-risk human
papillomavirus (HPV). Currently, prophylactic vaccines against HPV have been validated …

Systemic administration of a potent mouse monoclonal antibody provides multisite protection against HPV16 infection

B Huang, D Zhang, H Wang, S Li, J Guo, S Cui… - International …, 2024 - Elsevier
Although preventive vaccines for Human Papillomaviruses (HPV) are available, a definitive
cure for the viral infection itself is currently lacking. There is a sizable population that …

Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross …

CK Metz, AS Skof, J Sehouli, JP Siedentopf… - Archives of Gynecology …, 2023 - Springer
Purpose Invasive cervical cancer (ICC) is associated in nearly 100% with persistent high-
risk Human Papillomavirus (HR-HPV) infection. ICC is still one of the leading causes for …

Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study

B Traore, Y Kassogue, B Diakite, F Diarra… - BMC Infectious …, 2024 - Springer
Introduction Long-term exposure to high-risk human papillomavirus (Hr-HPV) is a well-
known necessary condition for development of cervical cancer. The aim of this study is to …